絞り込み

16507

広告

Dipeptidyl peptidase IV (DPP-IV) inhibition prevents fibrosis in adipose tissue of obese mice.

著者 Marques AP , Cunha-Santos J , Leal H , Sousa-Ferreira L , de Almeida LP , Cavadas C , Rosmaninho-Salgado J
Biochim Biophys Acta.2017 Nov 14 ; ():.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

スターを付ける スターを付ける     (75view , 0users)

Full Text Sources

Miscellaneous

During the development of obesity the expansion of white adipose tissue (WAT) leads to a dysregulation and an excessive remodeling of extracellular matrix (ECM), leading to fibrosis formation. These ECM changes have high impact on WAT physiology and may change obesity progression. Blocking WAT fibrosis may have beneficial effects on the efficacy of diet regimen or therapeutical approaches in obesity. Since dipeptidyl peptidase IV (DPP-IV) inhibitors prevent fibrosis in tissues, such as heart, liver and kidney, the objective of this study was to assess whether vildagliptin, a DPP-IV inhibitor, prevents fibrosis in WAT in a mouse model of obesity, and to investigate the mechanisms underlying this effect.
PMID: 29154902 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード